trial · primary record
DS1025a
Advanced Solid Tumor
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 45 |
| Primary completion | 2029-01-21 |
| Primary endpoint | Number of Participants Reporting Dose-limiting Toxicities (DLTs) |
| Registry ID | NCT07681882 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:21.121Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07681882
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.